Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

Falk Roeder

doi:10.4251/wjgo.v8.i2.186

Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

Falk Roeder^* (Erstautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

13 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	186-197
Fachzeitschrift	WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
Jahrgang	8
Ausgabenummer	2
DOIs	https://doi.org/10.4251/wjgo.v8.i2.186
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.4251/wjgo.v8.i2.186

Dieses zitieren

@article{de0450553e374e0297dd83c574eefd4d,

title = "Neoadjuvant radiotherapeutic strategies in pancreatic cancer.",

keywords = "INTRAOPERATIVE RADIATION-THERAPY, STEREOTACTIC BODY RADIOTHERAPY, GEMCITABINE-BASED CHEMORADIATION, LONG-TERM OUTCOMES, PREOPERATIVE CHEMORADIATION, DUCTAL ADENOCARCINOMA, RESECTABLE ADENOCARCINOMA, ADJUVANT CHEMOTHERAPY, IMPROVED SURVIVAL, RANDOMIZED-TRIAL",

author = "Falk Roeder",

year = "2016",

doi = "10.4251/wjgo.v8.i2.186",

language = "English",

volume = "8",

pages = "186--197",

journal = "WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY",

issn = "1948-5204",

number = "2",

}

TY - JOUR

T1 - Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

AU - Roeder, Falk

PY - 2016

Y1 - 2016

KW - INTRAOPERATIVE RADIATION-THERAPY

KW - STEREOTACTIC BODY RADIOTHERAPY

KW - GEMCITABINE-BASED CHEMORADIATION

KW - LONG-TERM OUTCOMES

KW - PREOPERATIVE CHEMORADIATION

KW - DUCTAL ADENOCARCINOMA

KW - RESECTABLE ADENOCARCINOMA

KW - ADJUVANT CHEMOTHERAPY

KW - IMPROVED SURVIVAL

KW - RANDOMIZED-TRIAL

U2 - 10.4251/wjgo.v8.i2.186

DO - 10.4251/wjgo.v8.i2.186

M3 - Review article

C2 - 26909133

SN - 1948-5204

VL - 8

SP - 186

EP - 197

JO - WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY

JF - WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY

IS - 2

ER -